urlscan.io logo urlscan.io
SecurityTrails logo

www.tevapharm.com Open in urlscan Pro
45.60.155.76  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: http://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection...
Effective URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection...
Submission: On June 18 via api from US
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 17 IPs in 5 countries across 15 domains to perform 92 HTTP transactions. The main IP is 45.60.155.76, located in United States and belongs to INCAPSULA, US. The main domain is www.tevapharm.com.
TLS certificate: Issued by GlobalSign CloudSSL CA - SHA256 - G3 on January 27th 2020. Valid for: 6 months.
This is the only time www.tevapharm.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

76    45.60.155.76 (United States)

ASN19551 (INCAPSULA, US)
www.tevapharm.com
1    2a00:1450:4001:825::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagmanager.com
1    2606:4700::6813:9408 (United States)

ASN13335 (CLOUDFLARENET, US)
script.crazyegg.com
2    216.58.205.230 (Mountain View, United States)

ASN15169 (GOOGLE, US)
PTR: fra15s24-in-f6.1e100.net
9705755.fls.doubleclick.net
1    2606:4700::6812:1d93 (United States)

ASN13335 (CLOUDFLARENET, US)
ssl.widgets.webengage.com
1    13.226.145.171 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-13-226-145-171.dus51.r.cloudfront.net
js.adsrvr.org
1    2a02:26f0:6c00:28c::25ea (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
snap.licdn.com
2    2a00:1450:4001:809::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google-analytics.com
2    2a03:2880:f01c:8012:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK, US)
connect.facebook.net
2    2a05:f500:11:101::b93f:9005 (Ireland)

ASN14413 (LINKEDIN, US)
px.ads.linkedin.com
1    2620:1ec:21::14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)
www.linkedin.com
1    2a00:1450:400c:c00::9d (Brussels, Belgium)

ASN15169 (GOOGLE, US)
stats.g.doubleclick.net
1    2a00:1450:4001:819::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.com
1    2a00:1450:4001:819::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.de
1    2a03:2880:f11c:8183:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK, US)
www.facebook.com
1    2600:9000:2057:2200:8:cf94:88c0:93a1 (United States)

ASN16509 (AMAZON-02, US)
11b564056.webengage.co
1    52.216.232.181 (Ashburn, United States)

ASN16509 (AMAZON-02, US)
PTR: s3-1.amazonaws.com
s3.amazonaws.com
1    54.208.95.246 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-208-95-246.compute-1.amazonaws.com
c.webengage.com
2    99.81.228.121 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-99-81-228-121.eu-west-1.compute.amazonaws.com
insight.adsrvr.org
2    63.33.80.49 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-63-33-80-49.eu-west-1.compute.amazonaws.com
match.adsrvr.org
Domain Requested by
76 www.tevapharm.com 1 redirects www.tevapharm.com
2 match.adsrvr.org js.adsrvr.org
2 insight.adsrvr.org 2 redirects
2 px.ads.linkedin.com 1 redirects www.tevapharm.com
2 connect.facebook.net www.tevapharm.com
connect.facebook.net
2 www.google-analytics.com 1 redirects www.googletagmanager.com
2 9705755.fls.doubleclick.net 1 redirects www.googletagmanager.com
1 c.webengage.com www.tevapharm.com
1 s3.amazonaws.com ssl.widgets.webengage.com
1 11b564056.webengage.co ssl.widgets.webengage.com
1 www.facebook.com www.tevapharm.com
1 www.google.de www.tevapharm.com
1 www.google.com 1 redirects
1 stats.g.doubleclick.net 1 redirects
1 www.linkedin.com 1 redirects
1 snap.licdn.com www.tevapharm.com
1 js.adsrvr.org www.googletagmanager.com
1 ssl.widgets.webengage.com www.tevapharm.com
1 script.crazyegg.com www.googletagmanager.com
1 www.googletagmanager.com www.tevapharm.com
92 20
Subject Issuer Validity Valid
incapsula.com
GlobalSign CloudSSL CA - SHA256 - G3		 2020-01-27 -
2020-08-03		 6 months crt.sh
*.google-analytics.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3		 2020-06-09 -
2021-06-09		 a year crt.sh
*.doubleclick.net
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
webengage.com
Cloudflare Inc ECC CA-3		 2020-05-24 -
2021-05-24		 a year crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1		 2019-03-07 -
2021-04-19		 2 years crt.sh
*.licdn.com
DigiCert SHA2 Secure Server CA		 2019-04-01 -
2021-05-07		 2 years crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA		 2020-05-14 -
2020-08-05		 3 months crt.sh
px.ads.linkedin.com
DigiCert SHA2 Secure Server CA		 2020-03-04 -
2020-09-04		 6 months crt.sh
www.google.de
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
webengage.co
Amazon		 2019-09-29 -
2020-10-29		 a year crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2		 2019-11-09 -
2020-12-02		 a year crt.sh
*.webengage.com
DigiCert SHA2 Secure Server CA		 2020-04-13 -
2021-04-21		 a year crt.sh

This page contains 5 frames:

Primary Page: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Frame ID: E89B95DBF0C950469F84FAB5688A6EE1
Requests: 93 HTTP requests in this frame

Frame: https://9705755.fls.doubleclick.net/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Frame ID: 130919C4895AA35D3A0D9D31EB9E9465
Requests: 1 HTTP requests in this frame

Frame: https://11b564056.webengage.co/storage-frame-1.16.htm?cdn=y&cbf=webengage-engagement-callback-frame&lc=11b564056
Frame ID: C84CF2FF804DC45DB4AB17AB2985AA3B
Requests: 1 HTTP requests in this frame

Frame: https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
Frame ID: E60F2582C5C98A6D310D97E990720BC2
Requests: 1 HTTP requests in this frame

Frame: https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
Frame ID: 361188529CEE641E46404AA301F26C7C
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. http://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiram... HTTP 301
    https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiram... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers server /^(?:Microsoft-)?IIS(?:\/([\d.]+))?/i
  • url /\.aspx?(?:$|\?)/i
Overall confidence: 100%
Detected patterns
  • url /\.aspx?(?:$|\?)/i
Overall confidence: 100%
Detected patterns
  • headers server /^(?:Microsoft-)?IIS(?:\/([\d.]+))?/i
  • url /\.aspx?(?:$|\?)/i
Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i
Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^/]*\/[a-z]*\.js/i
Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i
Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

92
Requests

100 %
HTTPS

65 %
IPv6

15
Domains

20
Subdomains

17
IPs

5
Countries

1892 kB
Transfer

3639 kB
Size

12
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx HTTP 301
    https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 3
  • https://9705755.fls.doubleclick.net/activityi;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx HTTP 302
  • https://9705755.fls.doubleclick.net/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Request Chain 23
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&time=1592456312184 HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D1460434%26url%3Dhttps%253A%252F%252Fwww.tevapharm.com%252Fnews%252Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx%26time%3D1592456312184%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&time=1592456312184&liSync=true
Request Chain 24
  • https://www.google-analytics.com/r/collect?v=1&_v=j83&a=1432265981&t=pageview&_s=1&dl=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&dp=%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&ul=EN&de=UTF-8&dt=error%20404&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAEAB~&jid=510871344&gjid=554349780&cid=2082367038.1592456312&tid=UA-16851568-1&_gid=1470571256.1592456312&_r=1&gtm=2wg6a0WWPN5T&cg1=error%20404&cg4=other&cd1=184210&cd2=article&cd3=other&cd5=2019-12-22&z=181790211 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_gid=1470571256.1592456312&gjid=554349780&_v=j83&z=181790211 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211&slf_rd=1&random=86435325
Request Chain 94
  • https://insight.adsrvr.org/track/up?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0 HTTP 302
  • https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
Request Chain 95
  • https://insight.adsrvr.org/track/up?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0 HTTP 302
  • https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0

92 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
Primary Request teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
www.tevapharm.com/news/
Redirect Chain
  • http://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
  • https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
242 KB
13 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET ARR/3.0
Resource Hash
e9b32a76da2d2d26f9c6de601a6e97f0e95e3877ce38386050c1e20c274c1c13

Request headers

:method
GET
:authority
www.tevapharm.com
:scheme
https
:path
/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
404
cache-control
private
content-type
text/html; charset=utf-8
server
Microsoft-IIS/10.0
set-cookie
ASP.NET_SessionId=cmvmayzc2xji2t4mjfyhte2t; path=/; HttpOnly; SameSite=Lax ARRAffinity=223242edffad9634629293fff1625d9fabbc117a1d9986a90aa14acc0ef3b705;Path=/;HttpOnly;Domain=www.tevapharm.com visid_incap_591826=/Vhq/2y4Qne8+w4qPJTlMnb06l4AAAAAQUIPAAAAAAAVHA9+wHhVJBZy19Thn8ee; expires=Thu, 17 Jun 2021 16:09:37 GMT; HttpOnly; path=/; Domain=.tevapharm.com incap_ses_769_591826=WT43AoB1Y3jHDLbowAqsCnf06l4AAAAAaBD+6xCpmP0NtQiljJqBNg==; path=/; Domain=.tevapharm.com
x-aspnetmvc-version
5.2
x-aspnet-version
4.0.30319
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
access-control-expose-headers
Request-Context
x-powered-by
ASP.NET ARR/3.0
date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
content-encoding
gzip
x-iinfo
2-5132978-5132979 NNYN CT(85 180 0) RT(1592456310117 0) q(0 0 2 0) r(13 13) U5

Redirect headers

Location
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Content-Length
0
Connection
close
css
www.tevapharm.com/news/DependencyHandler.axd/a293c13e0119e3574d4d0c5729ef0cd7/1/ 		571 KB
85 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/news/DependencyHandler.axd/a293c13e0119e3574d4d0c5729ef0cd7/1/css
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
f6919bad4320bdaec79c493e50fc457fa96e993dc7deba73cb656605436e5a30

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
content-encoding
gzip
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5132994-5132995 NNNY CT(0 0 0) RT(1592456311572 0) q(0 0 0 -1) r(2 2) U5
content-length
86266
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Thu, 18 Jun 2020 04:52:23 GMT
server
Microsoft-IIS/10.0
etag
"dbb0370f6cf923667b9d5150cecd8b16"
vary
Accept-Encoding
content-type
text/css
access-control-expose-headers
Request-Context
cache-control
public, must-revalidate, proxy-revalidate, max-age=863631, s-maxage=863631
expires
Sun, 28 Jun 2020 04:52:23 GMT
gtm.js
www.googletagmanager.com/ 		170 KB
50 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-WWPN5T
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
118e4124d9bf3c4b1304c0a54a8178ed992dbef8689d5f9b30ce1252cbc3a9c9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
content-encoding
br
vary
Accept-Encoding
status
200
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51508
x-xss-protection
0
last-modified
Thu, 18 Jun 2020 03:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 18 Jun 2020 04:58:32 GMT
3437.js
script.crazyegg.com/pages/scripts/0020/ 		0
0 		Script
General
Check archive.org
Download Go to
Full URL
https://script.crazyegg.com/pages/scripts/0020/3437.js?442349
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WWPN5T
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
cf-cache-status
HIT
last-modified
Thu, 11 Jun 2020 16:17:50 GMT
server
cloudflare
age
564042
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
410
cache-control
public, max-age=86400
cf-ray
5a526f8f0dcfd709-FRA
content-length
0
cf-request-id
0367640d680000d7099e832200000001
activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_...
9705755.fls.doubleclick.net/ Frame 1309
Redirect Chain
  • https://9705755.fls.doubleclick.net/activityi;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announce...
  • https://9705755.fls.doubleclick.net/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.te...
0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://9705755.fls.doubleclick.net/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx?
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WWPN5T
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.205.230 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s24-in-f6.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=21600
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
9705755.fls.doubleclick.net
:scheme
https
:path
/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx?
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
about:blank

Response headers

status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
timing-allow-origin
*
date
Thu, 18 Jun 2020 04:58:32 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
cache-control
no-cache, must-revalidate
strict-transport-security
max-age=21600
content-type
text/html; charset=UTF-8
pragma
no-cache
x-content-type-options
nosniff
content-encoding
gzip
server
cafe
content-length
459
x-xss-protection
0
set-cookie
test_cookie=CheckForPermission; expires=Thu, 18-Jun-2020 05:13:32 GMT; path=/; domain=.doubleclick.net; Secure; SameSite=none
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

Redirect headers

status
302
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
timing-allow-origin
*
date
Thu, 18 Jun 2020 04:58:32 GMT
pragma
no-cache
expires
Fri, 01 Jan 1990 00:00:00 GMT
cache-control
no-cache, must-revalidate
follow-only-when-prerender-shown
1
strict-transport-security
max-age=21600
location
https://9705755.fls.doubleclick.net/activityi;dc_pre=CO6Nv4bKiuoCFZXsdwodZSQCZA;src=9705755;type=count0;cat=unive0;ord=255716692485;gtm=2wg6a0;auiddc=903516101.1592456312;~oref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx?
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
server
cafe
content-length
0
x-xss-protection
0
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
webengage-min-v-4.0.js
ssl.widgets.webengage.com/js/widget/ 		186 KB
57 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ssl.widgets.webengage.com/js/widget/webengage-min-v-4.0.js
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:1d93 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1c3a5fdfa057e738048e1c8d06bccca607f5417f97699fe0c85c5a0850561f02

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
via
1.1 5c42606592ccd5dbe3b02deff8a08eda.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
4515
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
cf-request-id
0367640d80000005c4b21b4200000001
last-modified
Tue, 16 Jun 2020 17:21:17 GMT
server
cloudflare
etag
W/"5ee8ff8d-2e903"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=14400
x-amz-cf-pop
ATL56-C1
cf-ray
5a526f8f3cf005c4-FRA
x-amz-cf-id
VPboRDC9V6Okx-kIlPMRIHgD3kGJ0-oCllkeN46wike4il7Icr0hww==
expires
Thu, 18 Jun 2020 07:13:27 GMT
up_loader.1.1.0.js
js.adsrvr.org/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WWPN5T
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.226.145.171 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-226-145-171.dus51.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
0615974c40d602afdbf9759533e352bc17b0458c85aad6694b1a1ad20659625b

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Wed, 17 Jun 2020 16:28:38 GMT
Content-Encoding
gzip
Last-Modified
Mon, 13 Jan 2020 19:16:48 GMT
Server
AmazonS3
Age
60724
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 147cd286989da71c73312280bb09c200.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
DUS51-C1
X-Amz-Cf-Id
uTL0Sb_T6UlzeyxzpiJI2YsQ4mT2CCUdJlKVm2o-FtfgiFUnm8RgnA==
insight.min.js
snap.licdn.com/li.lms-analytics/ 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:28c::25ea , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
41dd5e421fe221a7d2921d6fa2b36e8b01a9f2c054aaef5fad866fe896c1d1e0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 18 Jun 2020 04:58:32 GMT
Content-Encoding
gzip
Last-Modified
Mon, 07 Oct 2019 16:41:31 GMT
X-CDN
AKAM
Vary
Accept-Encoding
Content-Type
application/x-javascript;charset=utf-8
Cache-Control
max-age=60174
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1576
analytics.js
www.google-analytics.com/ 		45 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WWPN5T
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
fd361b57998c76f86335afa28b8a62527d88a8200fb5c428d6f0fff73383e955
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 04 Jun 2020 23:38:14 GMT
server
Golfe2
age
1134
date
Thu, 18 Jun 2020 04:39:38 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18469
expires
Thu, 18 Jun 2020 06:39:38 GMT
fbevents.js
connect.facebook.net/en_US/ 		131 KB
31 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
4cb61e44bf63a9e090e666898cd04d382e4c33b55b62cc5e9ff7dab055fbf787
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
31766
x-xss-protection
0
pragma
public
x-fb-debug
85xlSfJ4Nzj83On6D29dHf4/EQ7NJVOV+hMSeaMYzQy1PDiyK/xya31uEX0YwgjFQ8LIRkyjW0Jf589xiGuRiQ==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Thu, 18 Jun 2020 04:58:32 GMT, Thu, 18 Jun 2020 04:58:32 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
canada-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		22 KB
22 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/canada-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
f5ae88cda886df232d2f17fcc20a3348500d5145ec6cd8056a5e4db4ee01c97c

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5132997-5132998 NNNY CT(0 0 0) RT(1592456311674 0) q(0 0 0 -1) r(1 1) U5
content-length
22409
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:43 GMT
usa-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		29 KB
29 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/usa-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
cbb13c796822063762d136ab8fa15a39ae177be4a765e5f54d4ff6c388be3d47

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5132999-5133000 NNNY CT(0 0 0) RT(1592456311676 0) q(0 0 0 -1) r(1 1) U5
content-length
29433
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:43 GMT
argentina-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		19 KB
20 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/argentina-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
cade2d34ae16a100817ed1ae410c74d2f7c4ea8fb6d06d596c932d6b13ac5bba

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133001-5133002 NNNY CT(0 0 0) RT(1592456311677 0) q(0 0 0 -1) r(1 1) U5
content-length
19849
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:43 GMT
australia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		27 KB
27 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/australia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
81c25fb299892defb0792f377fb746b3dc9bb7bfa762d4918dded4ad7a40c4a1

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133003-5133004 NNNN CT(85 85 0) RT(1592456311678 0) q(0 0 2 -1) r(3 4) U5
content-length
27985
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
belarus-132x78.png
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		3 KB
3 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/belarus-132x78.png
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3b6de434be457b1e3342963732a2c894f151234e83abf4c44c24db02b9edccd8

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133005-5133000 PNNy RT(1592456311678 0) q(0 2 2 -1) r(3 3) U5
content-length
2928
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/png
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
brazil-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		26 KB
27 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/brazil-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
ff7e25add87159d24246b4cee571cfca9de579175d3da3fec6434e86fdeea9e0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133006-5133002 PNNy RT(1592456311679 0) q(0 2 2 -1) r(3 3) U5
content-length
27055
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
chile-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/chile-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
e27ecfca3c4d1bf9f73790e5542f2996eac1aaebe69c7c6d13f5663a2fd7228e

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133007-5132998 PNNy RT(1592456311679 0) q(0 2 2 -1) r(3 3) U5
content-length
17766
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
china-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		21 KB
21 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/china-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
19c1f8e369507f1671a6f5fb94d45ae08e534cb6c13a683cfe0474fad075a244

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133008-5132979 PNNN RT(1592456311680 0) q(0 2 2 -1) r(3 3) U5
content-length
21092
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
hong-kong-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		4 KB
4 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/hong-kong-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3f611150343d68f897fd4262e32cc88336d5f542e4acdf98c0af40d4c55e5c41

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133009-5133000 PNNy RT(1592456311680 0) q(0 3 3 -1) r(4 4) U5
content-length
3647
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 18 Dec 2019 10:33:54 GMT
server
Microsoft-IIS/10.0
etag
"1D5B58EA5445500"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
india-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		20 KB
20 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/india-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
cbf295e40bf0f5a250196169097a1d00e56192c5367476a6375daef24b785495

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133010-5133002 PNNy RT(1592456311680 0) q(0 3 3 -1) r(4 4) U5
content-length
20407
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
israel-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		23 KB
23 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/israel-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
5fcc0b39423442307219967d5c31817126d2c6efb050028409049fdc682ed803

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133011-5132998 PNNy RT(1592456311687 0) q(0 3 3 -1) r(4 4) U5
content-length
23826
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
japan-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/japan-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
744705d196cc92f96b1e53988f948f116b2ebc6b88a7eb10e21c13bcd4a835f9

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133012-5132979 PNNN RT(1592456311687 0) q(0 3 3 -1) r(4 4) U5
content-length
16508
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
kazakhstan-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		24 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/kazakhstan-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
a69e31761b8e5c368a8ebcd702e6b7828faff746bd49567ee532fa971b3a1d47

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133013-5133000 PNNy RT(1592456311688 0) q(0 4 4 -1) r(5 5) U5
content-length
25062
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
kirgistan-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		4 KB
4 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/kirgistan-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3a4d2cae808ef518ae381d118505a314cd497096aace737624f6c5a072f78065

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133014-5133004 PNNN RT(1592456311688 0) q(0 4 4 -1) r(5 5) U5
content-length
4203
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
collect
px.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_4...
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D1460434%26url%3Dhttps%253A%252F%252Fwww.tevapharm.com%252Fnews%252Fteva_announces...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_4...
0
81 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&time=1592456312184&liSync=true
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:f500:11:101::b93f:9005 , Ireland, ASN14413 (LINKEDIN, US),
Reverse DNS
Software
Play /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:33 GMT
server
Play
linkedin-action
1
x-li-fabric
prod-lor1
status
200
x-li-proto
http/2
x-li-pop
prod-tln1
content-type
application/javascript
content-length
0
x-li-uuid
DTD1XJSKGRbAR84c0ioAAA==

Redirect headers

strict-transport-security
max-age=2592000
x-content-type-options
nosniff
linkedin-action
1
status
302
content-length
0
x-li-uuid
4aD1VZSKGRZwFnTIRysAAA==
pragma
no-cache
x-li-pop
afd-prod-esv5
x-msedge-ref
Ref A: 97F054BD26CB47B397E2F253BEBDFE59 Ref B: FRAEDGE1119 Ref C: 2020-06-18T04:58:32Z
date
Thu, 18 Jun 2020 04:58:32 GMT
expect-ct
max-age=86400, report-uri="https://www.linkedin.com/platform-telemetry/ct"
x-frame-options
sameorigin
x-li-fabric
prod-lor1
location
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=1460434&url=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&time=1592456312184&liSync=true
x-xss-protection
1; mode=block
cache-control
no-cache, no-store
content-security-policy
default-src *; connect-src 'self' https://media-src.linkedin.com/media/ www.linkedin.com s.c.lnkd.licdn.com m.c.lnkd.licdn.com s.c.exp1.licdn.com s.c.exp2.licdn.com m.c.exp1.licdn.com m.c.exp2.licdn.com wss://*.linkedin.com dms.licdn.com https://dpm.demdex.net/id https://lnkd.demdex.net/event blob: static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com media.licdn.com media-exp1.licdn.com media-exp2.licdn.com media-exp3.licdn.com; img-src data: blob: *; font-src data: *; style-src 'unsafe-inline' 'self' static-src.linkedin.com *.licdn.com; script-src 'report-sample' 'unsafe-inline' 'unsafe-eval' 'self' spdy.linkedin.com static-src.linkedin.com *.ads.linkedin.com *.licdn.com static.chartbeat.com www.google-analytics.com ssl.google-analytics.com bcvipva02.rightnowtech.com www.bizographics.com sjs.bizographics.com js.bizographics.com d.la4-c1-was.salesforceliveagent.com slideshare.www.linkedin.com https://snap.licdn.com/li.lms-analytics/insight.min.js platform.linkedin.com platform-akam.linkedin.com platform-ecst.linkedin.com platform-azur.linkedin.com; object-src 'none'; media-src blob: *; child-src blob: lnkd-communities: voyager: *; frame-ancestors 'self'; report-uri https://www.linkedin.com/platform-telemetry/csp?f=l
x-li-proto
http/2
expires
Thu, 01 Jan 1970 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j83&a=1432265981&t=pageview&_s=1&dl=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatira...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_gid=1470571256.1592456312&gjid=554349780&_v=j83&z=181790211
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211&slf_rd=1&random=86435325
42 B
106 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211&slf_rd=1&random=86435325
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 18 Jun 2020 04:58:32 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Thu, 18 Jun 2020 04:58:32 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-16851568-1&cid=2082367038.1592456312&jid=510871344&_v=j83&z=181790211&slf_rd=1&random=86435325
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
456364188330135
connect.facebook.net/signals/config/ 		147 KB
37 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/456364188330135?v=2.9.18&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
1f975a42fd2b1c8940d44d86ec00a21830f29b95406f0006fba3d82f75f11619
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
37508
x-xss-protection
0
pragma
private
x-fb-debug
mXcas+tOjp1GGAw52EYKtc35Tlan1tg61nlZIMNOsm3USvpwRhHH2wy8Go4zN1KHFgmm6Dngvrz5F8uFpp/iag==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Thu, 18 Jun 2020 04:58:32 GMT, Thu, 18 Jun 2020 04:58:32 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
private
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/ 		44 B
270 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=456364188330135&ev=PageView&dl=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&rl=&if=false&ts=1592456312231&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=28&fbp=fb.1.1592456312230.1770638880&it=1592456312211&coo=false&rqm=GET
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT, Thu, 18 Jun 2020 04:58:32 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Thu, 18 Jun 2020 04:58:32 GMT
storage-frame-1.16.htm
11b564056.webengage.co/ Frame C84C 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://11b564056.webengage.co/storage-frame-1.16.htm?cdn=y&cbf=webengage-engagement-callback-frame&lc=11b564056
Requested by
Host: ssl.widgets.webengage.com
URL: https://ssl.widgets.webengage.com/js/widget/webengage-min-v-4.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:2200:8:cf94:88c0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash

Request headers

:method
GET
:authority
11b564056.webengage.co
:scheme
https
:path
/storage-frame-1.16.htm?cdn=y&cbf=webengage-engagement-callback-frame&lc=11b564056
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx

Response headers

status
200
content-type
text/html
server
nginx/1.12.1
last-modified
Mon, 15 Oct 2018 09:59:05 GMT
access-control-allow-origin
*
content-encoding
gzip
date
Thu, 18 Jun 2020 01:08:38 GMT
expires
Thu, 18 Jun 2020 05:08:34 GMT
cache-control
max-age=14400
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 a56d6b55603697d6c44b19d4f907baaa.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amz-cf-id
Rmrax9AQcTnS7Jt5fLMoY7Ys2jtDuNSisX_b8LeXp_BEk-T35IXUkQ==
age
13798
mexico-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		3 KB
3 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/mexico-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3204d368f39b24eafcac036f40a671e82bfa28e3ea521ea688a9adae36ea55d9

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133015-5132998 PNNy RT(1592456311760 0) q(0 3 3 -1) r(4 4) U5
content-length
3215
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
peru-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/peru-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
1fdd0c3e09bb9591d9708782070900e27b0319055ad0191af18514973a6fefc6

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133016-5133004 PNNN RT(1592456311761 0) q(0 4 4 -1) r(4 4) U5
content-length
16859
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
russia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/russia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
73c4c1c826b0bfeaa05b0ec40caa0bdca57aa9f9620c5920162efce2b82c73d9

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133017-5133002 PNNy RT(1592456311762 0) q(0 4 4 -1) r(4 4) U5
content-length
17750
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
singapore-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		19 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/singapore-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
1420a08d4c417ea6453c343a9481ad20cf4cca5bfb6f32153a983b2588966d64

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133018-5133000 PNNy RT(1592456311763 0) q(0 4 4 -1) r(4 4) U5
content-length
19345
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
south_africa-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		26 KB
26 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/south_africa-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
9e398d2d266aae5bede397d09d4b8887e631cac23b4c691a2ed6fb110304902a

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133019-5132998 PNNy RT(1592456311763 0) q(0 4 4 -1) r(4 4) U5
content-length
26771
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
south_korea-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		24 KB
24 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/south_korea-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
960054b74a384c6c042340aaff0c491a2a2b3214ceb0afb6dc3e395647a728fd

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133020-5132979 PNNN RT(1592456311764 0) q(0 4 4 -1) r(5 5) U5
content-length
24196
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
thailand132x78.png
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		646 B
785 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/thailand132x78.png
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
83a4295b7a6bb17984f3ee2ec189c95e12ec1e977fb18de3778515dbbe3ac6fe

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133021-5133004 PNNN RT(1592456311765 0) q(0 4 4 -1) r(5 5) U5
content-length
646
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Fri, 29 Nov 2019 21:55:19 GMT
server
Microsoft-IIS/10.0
etag
"1D5A6FFB0C6FD80"
content-type
image/png
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
turkey-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		19 KB
20 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/turkey-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
11fc699b804685dc8313bf6e170f72a1f2374298835e93abc0071d4390eee356

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133022-5133002 PNNy RT(1592456311765 0) q(0 4 4 -1) r(5 5) U5
content-length
19868
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
ukraine-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ukraine-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
d49136318088e6954eaaab623db156e9bf58ccfcaabdd5c3e8da40d467c2d001

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133023-5133000 PNNy RT(1592456311766 0) q(0 4 4 -1) r(5 5) U5
content-length
17719
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
uruguay-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		27 KB
27 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/uruguay-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
4b43be0dd2526be5105416f2e7208f6623f88ff53b160be88207605f805e905a

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133024-5132998 PNNy RT(1592456311766 0) q(0 4 4 -1) r(5 5) U5
content-length
27531
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
austria-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/austria-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
dc73af69498b6eef1cc832400f0874ceb7095f8dd3930732cf47d2553e6d5335

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133025-5132995 PNNy RT(1592456311767 0) q(0 5 5 -1) r(5 5) U5
content-length
18329
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
belgium-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/belgium-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
c026b40ad71f18df29eaec327e23c47f3132ff1008cbba4b5c46c404c4abbbe8

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133026-5132979 PNNN RT(1592456311767 0) q(0 5 5 -1) r(6 6) U5
content-length
17463
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
bosnia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		24 KB
24 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/bosnia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
f11898b963b705bf80b7ed772b577faaff32ffbef6646822217fb37399bf22b5

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133027-5133004 PNNN RT(1592456311768 0) q(0 5 5 -1) r(6 6) U5
content-length
24594
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
bulgaria-132x782.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/bulgaria-132x782.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
54658c6bb6f60fcc52b249c4c0255cd2d848e742ceaa1140f2c4776a91105d69

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133028-5133002 PNNy RT(1592456311768 0) q(0 5 5 -1) r(6 6) U5
content-length
17653
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Mon, 25 Nov 2019 09:10:13 GMT
server
Microsoft-IIS/10.0
etag
"1D5A37025044880"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
croatia132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		23 KB
23 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/croatia132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
cd17af17632dabbacb1c51c5487c4b18847845f2af15c0239a99db14caedb8c1

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133029-5133000 PNNy RT(1592456311769 0) q(0 5 5 -1) r(6 6) U5
content-length
23645
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 27 Nov 2019 10:10:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A50AE8208900"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
czech-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/czech-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
1a7be1e984f9a6b0e7c2eaf354fb0729e858052c06cfe08412ef7a60e4c6bb39

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133030-5132998 PNNy RT(1592456311769 0) q(0 5 5 -1) r(6 6) U5
content-length
18624
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
denmark-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		20 KB
20 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/denmark-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
88ba1562045bd3d6be65bf044e3a6f9ab7824a3dba515561e5b2e47bdfec4acd

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133031-5132995 PNNy RT(1592456311770 0) q(0 5 5 -1) r(6 6) U5
content-length
20093
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
estonia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/estonia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
4249839a67a82dc2878b625a561b660d1c4f2ad854c501b565955e9cdf523bf6

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133032-5132979 PNNN RT(1592456311770 0) q(0 6 6 -1) r(7 7) U5
content-length
17379
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
finland-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/finland-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
d66beb03e7108e4b415af012796c64247759a040af7a80375a7d520ccbcf97b4

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133033-5133004 PNNN RT(1592456311770 0) q(0 6 6 -1) r(7 7) U5
content-length
17946
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
france-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/france-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
c6070ba7b1d491c9c4d252a1d73bf05846f1cefba6da1c7ea2195e1731183ee2

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133034-5133002 PNNy RT(1592456311771 0) q(0 6 6 -1) r(7 7) U5
content-length
17287
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
germany-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/germany-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
f65fefeac2a0675abf8ccc80b82b2797ae0f0ccf2b28d88156770895fdf05cff

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133035-5133000 PNNy RT(1592456311775 0) q(0 6 6 -1) r(7 7) U5
content-length
17296
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
greece-132x78.png
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		1 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/greece-132x78.png
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
ef0fee79b36fcabfe2ecbecbb68e0e4eb8815abaf5a198d4a830700b448a68cc

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133036-5132998 PNNy RT(1592456311775 0) q(0 6 6 -1) r(7 7) U5
content-length
1446
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/png
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
hungary-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/hungary-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
90791d4af76e6875921be823c89cdbd6c67cf899f2414354a1c601559ceb2a03

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133037-5132995 PNNy RT(1592456311776 0) q(0 6 6 -1) r(7 7) U5
content-length
18068
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
iceland-132x78.png
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		659 B
767 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/iceland-132x78.png
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
eee0286f1ec0af27a810c23fc7fdc22487a3471c46aff2d0c9bb9a077bd9e0f6

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133038-5132979 PNNN RT(1592456311776 0) q(0 7 7 -1) r(7 7) U5
content-length
659
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/png
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
ireland-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ireland-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
c8d9641236c84044dad81dbb7d17c026ad67d2c331b0102ea927f99a3aa5f88b

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133039-5133004 PNNN RT(1592456311777 0) q(0 7 7 -1) r(8 8) U5
content-length
16597
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
italy-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/italy-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
b57a21031d17d39481496db23e67ed850545033abf819c5708408b6786388f01

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133040-5133002 PNNy RT(1592456311778 0) q(0 7 7 -1) r(8 8) U5
content-length
16449
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
latvia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/latvia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
4a7388c184fd64ad9279e161aa1cb6f7b83aaae2697e9dde0b4e78d7d2107c13

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133041-5133000 PNNy RT(1592456311778 0) q(0 7 7 -1) r(8 8) U5
content-length
18923
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
lithunia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/lithunia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
de47bcd6eb095b6a03a787ab89420e210340860855121645c5967598e510f741

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133042-5132998 PNNy RT(1592456311779 0) q(0 7 7 -1) r(8 8) U5
content-length
17553
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
macedonia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		33 KB
33 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/macedonia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
ba9a891e51d4d2dc2a66269ad427fea27d330ea614e4249f78118f9d548806a5

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133043-5132995 PNNy RT(1592456311779 0) q(0 7 7 -1) r(8 8) U5
content-length
33404
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
monaco-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/monaco-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
c9f1749d6e430c8dfa1365f801cff88eda1dbc0ae3a17cb79e70f965d1d2ea0f

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133044-5132979 PNNN RT(1592456311779 0) q(0 7 7 -1) r(8 8) U5
content-length
15986
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
netherlands-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/netherlands-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
fa051f1f31ad3000937247da4123e89deef331bbaa9a5a25a9b98422f2267b61

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133045-5133004 PNNN RT(1592456311780 0) q(0 8 8 -1) r(9 9) U5
content-length
17691
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
norway-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		24 KB
24 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/norway-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
7a04e4c905d1fc861fcd5a8572ef6557b6625841f0433daab61a839f13dba676

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133046-5133002 PNNy RT(1592456311780 0) q(0 8 8 -1) r(9 9) U5
content-length
24246
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
poland-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/poland-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3ef44044980fbaa96b15c180adc6002ae465951197cf1a5bb3eb8b266ebf329a

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133047-5133000 PNNy RT(1592456311828 0) q(0 7 7 -1) r(8 8) U5
content-length
16185
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
portugal-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		22 KB
22 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/portugal-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
75292c147dc0d2861e4a355506c754ac04380fbdb639fa2c5de65042bbf8c1f1

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133048-5132998 PNNy RT(1592456311828 0) q(0 7 7 -1) r(8 8) U5
content-length
22051
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
romania-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/romania-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
393cef8dc7be1257a7b7a2b98e7b1796ada6ba7e0ad08a6f25b7208044b037f1

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133049-5132995 PNNy RT(1592456311829 0) q(0 7 7 -1) r(8 8) U5
content-length
16731
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
serbia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		25 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/serbia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
cee926fb5c839ca4c14b1ea17645005f04ae5d5a0aae3ea80b387b6b2b815971

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133050-5132979 PNNN RT(1592456311830 0) q(0 7 7 -1) r(8 8) U5
content-length
25568
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
slovakia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		21 KB
21 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/slovakia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
29be774a3b44ee96590ad66d792d9fc0b59ec160bec46b7099aaa078ebf981fa

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133051-5133004 PNNN RT(1592456311830 0) q(0 8 8 -1) r(8 8) U5
content-length
21741
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
slovenia-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/slovenia-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
3cd00e653b8226892bdfe3981dcfef7131c9410be0cb59a2a3b21670398292bc

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133052-5133002 PNNy RT(1592456311831 0) q(0 8 8 -1) r(8 8) U5
content-length
18691
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
spain-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		3 KB
3 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/spain-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
4e2322bca2afacd8a478a06decaa8379edc94b5e879a58ee14297aecf6cd6f37

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133053-5133000 PNNy RT(1592456311831 0) q(0 8 8 -1) r(8 8) U5
content-length
2936
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
sweden-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		19 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/sweden-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
083a9a2bc33d17575212715e0e440b97bbd721a1fe3a665620efe2464c6f8b45

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133054-5132998 PNNy RT(1592456311832 0) q(0 8 8 -1) r(9 9) U5
content-length
19438
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
switzerland-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		18 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/switzerland-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
bed418c42bf06734ffd3aa9ab342e58e6c23d5feaed9fa046856ab9a87844b10

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133055-5132995 PNNy RT(1592456311832 0) q(0 8 8 -1) r(9 9) U5
content-length
17924
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
united_kingdom-132x78.jpg
www.tevapharm.com/globalassets/tevapharm-vision/country-flag/ 		34 KB
34 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/country-flag/united_kingdom-132x78.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
fba9eb080854e520edecab64de4b5183285e5387ea143729f8f98f7a67cf57fd

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133056-5132979 PNNN RT(1592456311833 0) q(0 8 8 -1) r(9 9) U5
content-length
35062
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 24 Nov 2019 08:59:34 GMT
server
Microsoft-IIS/10.0
etag
"1D5A2A57DBADF00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
family-walking-316x316.jpg
www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/ 		59 KB
59 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/family-walking-316x316.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
e2fd3ce29f1234eef3681b064689f225b9de51d6002b92853c579e4c0642c03c

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133058-5133004 PNNN RT(1592456311911 0) q(0 7 7 -1) r(8 8) U5
content-length
59945
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 10 Nov 2019 09:44:51 GMT
server
Microsoft-IIS/10.0
etag
"1D597AB7F67AB80"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
pills_shelves_teaser_316x316.jpg
www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/ 		22 KB
22 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/pills_shelves_teaser_316x316.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
31b07b502a5124fd167a1050cb8d7cff401a1883fc4995a82fd46646493437ed

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133059-5133002 PNNy RT(1592456311912 0) q(0 7 7 -1) r(8 8) U5
content-length
22217
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Tue, 07 Aug 2018 06:06:47 GMT
server
Microsoft-IIS/10.0
etag
"1D42E14D2B6B580"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
people-traveling316x316.jpg
www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/ 		48 KB
48 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/people-traveling316x316.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
ed22ab88506db0355b740cde4706fdf49d78f9047d5da088246fa13e2da82292

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133060-5133000 PNNy RT(1592456311913 0) q(0 7 7 -1) r(8 8) U5
content-length
49279
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 10 Nov 2019 17:28:21 GMT
server
Microsoft-IIS/10.0
etag
"1D597EC3F74E880"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
people_talking_terrace_316x316.jpg
www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/ 		39 KB
39 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/scs-branded-images/small-teaser-images/people_talking_terrace_316x316.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
b3e109fe43f16eec1ee4b042c81c59a3f6e293159cc39067b5976abc12fe1de0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133061-5132998 PNNy RT(1592456311913 0) q(0 8 8 -1) r(9 9) U5
content-length
39439
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Mon, 01 Jul 2019 08:56:41 GMT
server
Microsoft-IIS/10.0
etag
"1D52FEAE64DAA80"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
logo_teva.svg
www.tevapharm.com/globalassets/tevapharm-vision/logo/ 		3 KB
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/logo/logo_teva.svg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
a2348f0ebdd58ba89d9b6057ead8c96b18b432f86533d98699a37c7ad0fd4c1f

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
content-encoding
gzip
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133062-5132995 PNYy RT(1592456311914 0) q(0 8 8 -1) r(9 9) U5
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Mon, 16 Dec 2019 09:28:57 GMT
server
Microsoft-IIS/10.0
etag
"1D5B3F33DA5D280"
content-type
image/svg+xml
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
coffee400x400.jpg
www.tevapharm.com/globalassets/tevapharm-vision/ 		29 KB
29 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/coffee400x400.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
08f75dbed061ff19d0f3ad9d04ef82949be0683bb64aff41a6851b7021df0a3b

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133064-5132979 PNNN RT(1592456311915 0) q(0 8 8 -1) r(9 9) U5
content-length
29862
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 22 Dec 2019 09:55:26 GMT
server
Microsoft-IIS/10.0
etag
"1D5B8ADEF3E7B00"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:46:44 GMT
group-women-sports-teams400x400.jpg
www.tevapharm.com/globalassets/tevapharm-vision/featured-stories/ 		31 KB
31 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/featured-stories/group-women-sports-teams400x400.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
50d6252220d61326d999aed2c29e5bcde95573ca3b80c1a7e9fd21fbd14b41f7

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133065-5133004 PNNN RT(1592456311916 0) q(0 8 8 -1) r(9 9) U5
content-length
31456
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 22 Dec 2019 10:03:53 GMT
server
Microsoft-IIS/10.0
etag
"1D5B8AF1D708A80"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:46:44 GMT
friends-terrace400x400.jpg
www.tevapharm.com/globalassets/tevapharm-vision/career/ 		34 KB
35 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/career/friends-terrace400x400.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
ce1f40b029b07fa58ed78d1a8e6c69a6df1cc540f38447a948220fbda7cae81a

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133066-5133002 PNNy RT(1592456311916 0) q(0 8 8 -1) r(9 9) U5
content-length
35227
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Sun, 22 Dec 2019 10:01:41 GMT
server
Microsoft-IIS/10.0
etag
"1D5B8AECEC2F080"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:46:44 GMT
doctors-meeting200x200.jpg
www.tevapharm.com/globalassets/tevapharm-vision/ 		13 KB
13 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/doctors-meeting200x200.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
a5630b6c313364471eaeff1e66bafdbab274bbbd48044954aee0638580bf96f1

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133067-5133000 PNNy RT(1592456311917 0) q(0 8 8 -1) r(9 9) U5
content-length
13673
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 04 Dec 2019 22:52:01 GMT
server
Microsoft-IIS/10.0
etag
"1D5AAF57097BE80"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
woman_lab_200x200.jpg
www.tevapharm.com/globalassets/tevapharm-vision/ 		9 KB
9 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/woman_lab_200x200.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
03920600c78eb0f7efb55d95936bc428f3ab1d2fcbb3d1b867508fe6bb19c3f0

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133068-5132998 PNNy RT(1592456311917 0) q(0 9 9 -1) r(9 9) U5
content-length
9091
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 04 Dec 2019 22:38:50 GMT
server
Microsoft-IIS/10.0
etag
"1D5AAF3991EB900"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
mother-with-child200x200.jpg
www.tevapharm.com/globalassets/tevapharm-vision/ 		15 KB
15 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/mother-with-child200x200.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
a926c77a97e5371dcac5421e3cc3aa4931845a5d19e8cbd7488d977ed5d19969

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133069-5132995 PNNy RT(1592456311917 0) q(0 9 9 -1) r(10 10) U5
content-length
15571
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 04 Dec 2019 22:38:50 GMT
server
Microsoft-IIS/10.0
etag
"1D5AAF3991EB900"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
meeting200x200.jpg
www.tevapharm.com/globalassets/tevapharm-vision/ 		14 KB
14 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/globalassets/tevapharm-vision/meeting200x200.jpg
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
30d0a683d78428196e425b9ca8aa7f2c4e2d7a490fb87bc299f6eb6e0e70e6e8

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:32 GMT
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133070-5132979 PNNN RT(1592456311918 0) q(0 9 9 -1) r(10 10) U5
content-length
14441
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Wed, 04 Dec 2019 22:52:01 GMT
server
Microsoft-IIS/10.0
etag
"1D5AAF57097BE80"
content-type
image/jpeg
access-control-expose-headers
Request-Context
cache-control
public
accept-ranges
bytes
expires
Fri, 19 Jun 2020 04:19:44 GMT
js
www.tevapharm.com/news/DependencyHandler.axd/2ffa8dac6546d671fc30205a926fa4da/1/ 		630 KB
178 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/news/DependencyHandler.axd/2ffa8dac6546d671fc30205a926fa4da/1/js
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
c3c4f41866aef02d4f3d8c425ff368219bc6c6e885541031a6d673280fd32d79

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
content-encoding
gzip
x-cdn
Incapsula
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET, ARR/3.0
status
200
x-iinfo
2-5133063-5132995 PNNy RT(1592456311915 0) q(0 0 0 -1) r(1 1) U5
content-length
182399
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified
Thu, 18 Jun 2020 04:53:20 GMT
server
Microsoft-IIS/10.0
etag
"6fc76327bb10344f1b30a72742e47c55"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-expose-headers
Request-Context
cache-control
public, must-revalidate, proxy-revalidate, max-age=863687, s-maxage=863687
expires
Sun, 28 Jun 2020 04:53:20 GMT
_Incapsula_Resource
www.tevapharm.com/ 		113 KB
16 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/_Incapsula_Resource?SWJIYLWA=719d34d31c8e3a6e6fffd425f7e032f3&ns=1&cb=653960588
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
/
Resource Hash
4b379a2d024161a1e2815b65c1c9135e932cc2b385bd665a86f096d6c3b62f45

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
content-encoding
gzip
cache-control
no-cache, no-store
x-robots-tag
noindex
content-length
16667
content-type
application/javascript
TevaSansWeb-Regular-ef86efcd691fe3d33fca9305edb44668.woff2
www.tevapharm.com/modules/TeVa.SCS/Client/TevaPharm/Fonts/ 		38 KB
39 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/modules/TeVa.SCS/Client/TevaPharm/Fonts/TevaSansWeb-Regular-ef86efcd691fe3d33fca9305edb44668.woff2
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
4abe5ef6fe2a7da29132dc2622b4177ada956400b436d38bb9b2bd914f60e7af

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.tevapharm.com/news/DependencyHandler.axd/a293c13e0119e3574d4d0c5729ef0cd7/1/css
Origin
https://www.tevapharm.com

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
content-encoding
gzip
etag
"8abf22df42d61:0"
last-modified
Mon, 15 Jun 2020 06:34:23 GMT
server
Microsoft-IIS/10.0
x-powered-by
ASP.NET, ARR/3.0
content-type
application/font-woff
status
200
x-iinfo
2-5133072-5133002 PNYy RT(1592456311979 0) q(0 1 1 -1) r(2 2) U5
access-control-expose-headers
Request-Context
cache-control
max-age=86400
accept-ranges
bytes
x-cdn
Incapsula
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
truncated
/ 		1 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9a3a54de195d3fb7742c26b41e20bdbd26b01de8d7c921b9bf0c75db07dd32c

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/ 		1 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b18654c87ea0d8f7bac49b9d6af51945be2aa925db1d30b28255c64d39fddec8

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/ 		260 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
347b51ffddff3646a0705086ce58f156f613990a1fce9a707ff47cc056060c3a

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/ 		266 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7eca2b800fa2d8cc572bffceaa8d86d89cf1e8f462d16ee65aaa57fb4c87321b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/ 		272 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3b9f791f91fdeb248566e9bf5f9b54df995a1811c77869483ecceffdc538b44f

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
TevaSansWeb-Bold-94d127296b23f227a76256e53e315e25.woff2
www.tevapharm.com/modules/TeVa.SCS/Client/TevaPharm/Fonts/ 		40 KB
40 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.tevapharm.com/modules/TeVa.SCS/Client/TevaPharm/Fonts/TevaSansWeb-Bold-94d127296b23f227a76256e53e315e25.woff2
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash
90450f83b1809d0de69542722fc84150585a6eca8c92b45777c741624d6affb8

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.tevapharm.com/news/DependencyHandler.axd/a293c13e0119e3574d4d0c5729ef0cd7/1/css
Origin
https://www.tevapharm.com

Response headers

date
Thu, 18 Jun 2020 04:58:31 GMT
content-encoding
gzip
etag
"f9b212df42d61:0"
last-modified
Mon, 15 Jun 2020 06:34:23 GMT
server
Microsoft-IIS/10.0
x-powered-by
ASP.NET, ARR/3.0
content-type
application/font-woff
status
200
x-iinfo
2-5133075-5132979 PNYN RT(1592456312041 0) q(0 0 0 -1) r(1 1) U5
access-control-expose-headers
Request-Context
cache-control
max-age=86400
accept-ranges
bytes
x-cdn
Incapsula
request-context
appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
_Incapsula_Resource
www.tevapharm.com/ 		1 B
65 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.tevapharm.com/_Incapsula_Resource?SWKMTFSR=1&e=0.4147198552638023
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
45.60.155.76 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
cache-control
no-cache, no-store
x-robots-tag
noindex
content-length
1
content-type
text/plain
v4.js
s3.amazonaws.com/webengage-files/webengage/11b564056/ 		0
0 		Script
General
Check archive.org
Download Go to
Full URL
https://s3.amazonaws.com/webengage-files/webengage/11b564056/v4.js?r=26540938
Requested by
Host: ssl.widgets.webengage.com
URL: https://ssl.widgets.webengage.com/js/widget/webengage-min-v-4.0.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.232.181 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
/
Resource Hash

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
e.jpg
c.webengage.com/ 		0
348 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.webengage.com/e.jpg?event=Failed%20to%20load%20script%20%2F%2Fs3.amazonaws.com%2Fwebengage-files%2Fwebengage%2F11b564056%2Fv4.js%3Fr%3D26540938&category=11b564056&type=error&data=%7B%22version%22%3A%224.0%22%2C%20%22text%22%3A%22Error%3A%20Failed%20to%20load%20script%20%5C%2F%5C%2Fs3.amazonaws.com%5C%2Fwebengage-files%5C%2Fwebengage%5C%2F11b564056%5C%2Fv4.js%3Fr%3D26540938%5Cn%20%20%20%20at%20HTMLScriptElement.r.onerror%20(https%3A%5C%2F%5C%2Fssl.widgets.webengage.com%5C%2Fjs%5C%2Fwidget%5C%2Fwebengage-min-v-4.0.js%3A2%3A25409)%22%7D&ts=1592456313452
Requested by
Host: www.tevapharm.com
URL: https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.208.95.246 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-208-95-246.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 18 Jun 2020 04:58:33 GMT
x-content-type-options
nosniff
status
200
x-download-options
noopen
x-frame-options
SAMEORIGIN
access-control-allow-methods
GET, POST, OPTIONS
content-type
image/jpeg
access-control-allow-origin
*
access-control-allow-credentials
true
strict-transport-security
max-age=15552000; includeSubDomains
x-dns-prefetch-control
off
access-control-allow-headers
X-Requested-With,content-type
x-xss-protection
1; mode=block
/
match.adsrvr.org/track/upb/ Frame E60F
Redirect Chain
  • https://insight.adsrvr.org/track/up?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_1...
  • https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_1...
0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
63.33.80.49 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-63-33-80-49.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
match.adsrvr.org
:scheme
https
:path
/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
TDID=754b147b-4d5d-43f0-82b2-b5a758c054ee
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx

Response headers

status
200
date
Thu, 18 Jun 2020 04:58:33 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"

Redirect headers

status
302
date
Thu, 18 Jun 2020 04:58:33 GMT
content-type
text/html; charset=utf-8
location
https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
set-cookie
TDID=754b147b-4d5d-43f0-82b2-b5a758c054ee; domain=.adsrvr.org; expires=Fri, 18-Jun-2021 04:58:33 GMT; path=/; secure; SameSite=None
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
/
match.adsrvr.org/track/upb/ Frame 3611
Redirect Chain
  • https://insight.adsrvr.org/track/up?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_1...
  • https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_1...
0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
63.33.80.49 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-63-33-80-49.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
match.adsrvr.org
:scheme
https
:path
/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
TDID=754b147b-4d5d-43f0-82b2-b5a758c054ee
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.tevapharm.com/news/teva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx

Response headers

status
200
date
Thu, 18 Jun 2020 04:58:33 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"

Redirect headers

status
302
date
Thu, 18 Jun 2020 04:58:33 GMT
content-type
text/html; charset=utf-8
location
https://match.adsrvr.org/track/upb/?adv=zgfrg5h&ref=https%3A%2F%2Fwww.tevapharm.com%2Fnews%2Fteva_announces_u_s_fda_approval_of_three_times_a_week_copaxone_glatiramer_acetate_injection_40mg_ml_01_14.aspx&upid=ypjf9jq&upv=1.1.0
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
set-cookie
TDID=9fb2af5f-38c7-40a6-8122-aa052f4fed1d; domain=.adsrvr.org; expires=Fri, 18-Jun-2021 04:58:33 GMT; path=/; secure; SameSite=None
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"

Verdicts & Comments Add Verdict or Comment

39 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| udata object| dataLayer object| google_tag_manager object| google_tag_data object| myTMS object| _modifiedEvents object| _weq string| _linkedin_partner_id object| _linkedin_data_partner_ids string| GoogleAnalyticsObject function| ga function| fbq function| _fbq function| lintrk boolean| _already_called_lintrk object| gaplugins object| gaGlobal object| gaData object| webengage function| ttd_dom_ready function| TTDUniversalPixelApi function| setupLinks function| findObjectByKey function| getDisclaimerCookie function| setDisclaimerCookie function| checkDisclaimerCookie function| closeCookieDisclaimer function| showPopup function| pushGtmLog function| $ function| jQuery function| Popper object| vi object| Stickyfill object| Prism function| DataLayerPush function| EventDataLayerPush

12 Cookies

Domain/Path Name / Value
.doubleclick.net/ Name: test_cookie
Value: CheckForPermission
.www.tevapharm.com/ Name: ARRAffinity
Value: 223242edffad9634629293fff1625d9fabbc117a1d9986a90aa14acc0ef3b705
.tevapharm.com/ Name: _gat_UA-16851568-1
Value: 1
www.tevapharm.com/ Name: ___utmvc
Value: 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
.tevapharm.com/ Name: _gid
Value: GA1.2.1470571256.1592456312
.tevapharm.com/ Name: _ga
Value: GA1.2.2082367038.1592456312
.tevapharm.com/ Name: myt_storevisit
Value:
.tevapharm.com/ Name: visid_incap_591826
Value: /Vhq/2y4Qne8+w4qPJTlMnb06l4AAAAAQUIPAAAAAAAVHA9+wHhVJBZy19Thn8ee
.tevapharm.com/ Name: _gcl_au
Value: 1.1.903516101.1592456312
.tevapharm.com/ Name: _fbp
Value: fb.1.1592456312230.1770638880
www.tevapharm.com/ Name: ASP.NET_SessionId
Value: cmvmayzc2xji2t4mjfyhte2t
.tevapharm.com/ Name: incap_ses_769_591826
Value: WT43AoB1Y3jHDLbowAqsCnf06l4AAAAAaBD+6xCpmP0NtQiljJqBNg==

1 Console Messages

Source Level URL
Text
console-api log URL: https://ssl.widgets.webengage.com/js/widget/webengage-min-v-4.0.js(Line 2)
Message:
%cWebEngage%c %cERROR color: #FFFFFF; background-color: #533370; padding: 2px 4px 1px 4px; border-radius: 2px color: #FFFFFF; background-color: #FF0048; padding: 2px 4px 1px 4px; border-radius: 2px Failed to load script //s3.amazonaws.com/webengage-files/webengage/11b564056/v4.js?r=26540938 Error: Failed to load script //s3.amazonaws.com/webengage-files/webengage/11b564056/v4.js?r=26540938

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

11b564056.webengage.co
9705755.fls.doubleclick.net
c.webengage.com
connect.facebook.net
insight.adsrvr.org
js.adsrvr.org
match.adsrvr.org
px.ads.linkedin.com
s3.amazonaws.com
script.crazyegg.com
snap.licdn.com
ssl.widgets.webengage.com
stats.g.doubleclick.net
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.linkedin.com
www.tevapharm.com
13.226.145.171
216.58.205.230
2600:9000:2057:2200:8:cf94:88c0:93a1
2606:4700::6812:1d93
2606:4700::6813:9408
2620:1ec:21::14
2a00:1450:4001:809::200e
2a00:1450:4001:819::2003
2a00:1450:4001:819::2004
2a00:1450:4001:825::2008
2a00:1450:400c:c00::9d
2a02:26f0:6c00:28c::25ea
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
2a05:f500:11:101::b93f:9005
45.60.155.76
52.216.232.181
54.208.95.246
63.33.80.49
99.81.228.121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